BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21736847)

  • 21. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson's disease: a case-control study in Japan.
    Miyake Y; Tanaka K; Fukushima W; Sasaki S; Kiyohara C; Tsuboi Y; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    Parkinsonism Relat Disord; 2011 Feb; 17(2):112-6. PubMed ID: 21169048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
    Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol consumption pattern and risk of Barrett's oesophagus and erosive oesophagitis: an Italian case-control study.
    Filiberti RA; Fontana V; De Ceglie A; Blanchi S; Grossi E; Della Casa D; Lacchin T; De Matthaeis M; Ignomirelli O; Cappiello R; Rosa A; Foti M; Laterza F; D'Onofrio V; Iaquinto G; Conio M
    Br J Nutr; 2017 Apr; 117(8):1151-1161. PubMed ID: 28478792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta analysis: Cancer risk in Barrett's oesophagus.
    Thomas T; Abrams KR; De Caestecker JS; Robinson RJ
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1465-77. PubMed ID: 17900269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrett's oesophagus: a clinical study of 52 patients.
    Cooper BT; Barbezat GO
    Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: gastro-oesophageal reflux disease -- how wide is its span?
    Talley NJ
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():27-37; discussion 38-9. PubMed ID: 15456461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?
    Lagergren J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i1-5. PubMed ID: 15711002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
    BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term risk of oesophagitis, Barrett's oesophagus and oesophageal cancer in achalasia patients.
    Leeuwenburgh I; Haringsma J; Van Dekken H; Scholten P; Siersema PD; Kuipers EJ
    Scand J Gastroenterol Suppl; 2006; (243):7-10. PubMed ID: 16782616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers in Barrett's oesophagus and oesophageal adenocarcinoma.
    Paterson AL; Fitzgerald RC
    Expert Opin Med Diagn; 2007 Nov; 1(3):363-76. PubMed ID: 23489356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
    Kubo A; Corley DA; Jensen CD; Kaur R
    Nutr Res Rev; 2010 Dec; 23(2):230-46. PubMed ID: 20624335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
    Wild CP; Hardie LJ
    Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies.
    Huncharek M; Muscat J; Kupelnick B
    Nutr Cancer; 2009; 61(1):47-69. PubMed ID: 19116875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study.
    Abbas S; Linseisen J; Chang-Claude J
    Nutr Cancer; 2007; 59(1):54-61. PubMed ID: 17927502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fiber intake and risk of adenocarcinomas of the esophagus and stomach.
    Wu AH; Tseng CC; Hankin J; Bernstein L
    Cancer Causes Control; 2007 Sep; 18(7):713-22. PubMed ID: 17562192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of p53 in Barrett's oesophagus.
    Krishnadath KK; van Blankenstein M; Tilanus HW
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):81-4. PubMed ID: 7866817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.